๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chromatin modifications as therapeutic targets in MLL-rearranged leukemia

โœ Scribed by Aniruddha J. Deshpande; James Bradner; Scott A. Armstrong

Book ID
119263104
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
752 KB
Volume
33
Category
Article
ISSN
1471-4906

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Late-appearing MLL rearrangement arising
Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia
โœ David Rowe; Gareth J. Breese; Anne Lennard; Nick Bown ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 537 KB

## Abstract Rearrangements of __MLL__ are regarded as primary oncogenic events in acute leukemia. We report the case of a patient with acute myeloid leukemia with a complex abnormal karyotype at diagnosis who showed a putative stem line with monosomy 5 and a rearrangement of chromosome 17 as the on

The Syk kinase as a therapeutic target i
The Syk kinase as a therapeutic target in leukemia and lymphoma
โœ Efremov, Dimitar G; Laurenti, Luca ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Informa plc ๐ŸŒ English โš– 658 KB

## Introduction: The b-cell receptor (bcr) delivers antigen-dependent and -independent signals that have been implicated in the pathogenesis of several common b-cell malignancies. agents that can efficiently block bcr signaling have recently been developed and are currently being evaluated as novel